Intra-Cellular Therapies
ITCI
#1801
Rank
ยฃ7.05 B
Marketcap
ยฃ66.57
Share price
-0.36%
Change (1 day)
49.82%
Change (1 year)

Earnings for Intra-Cellular Therapies (ITCI)

Earnings in 2024 (TTM): -ยฃ66.51 Million

According to Intra-Cellular Therapies's latest financial reports the company's current earnings are ยฃ0.56 Billion. In 2023 the company made an earning of -ยฃ0.11 Billion, an increase over its 2022 earnings that were of -ยฃ0.2 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Intra-Cellular Therapies from 2014 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -ยฃ66.51 Million-38.05%
2023 -ยฃ0.11 Billion-45.74%
2022 -ยฃ0.2 Billion-9.81%
2021 -ยฃ0.22 Billion25.17%
2020 -ยฃ0.18 Billion53.66%
2019 -ยฃ0.12 Billion-4.77%
2018 -ยฃ0.12 Billion56.96%
2017 -ยฃ76.31 Million-14.33%
2016 -ยฃ89.07 Million10.09%
2015 -ยฃ80.91 Million241.45%
2014 -ยฃ23.7 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-ยฃ6.31 Million-90.21%๐Ÿ‡บ๐Ÿ‡ธ USA
-ยฃ35.99 Million-44.11%๐Ÿ‡บ๐Ÿ‡ธ USA
-ยฃ0.14 Billion 108.31%๐Ÿ‡บ๐Ÿ‡ธ USA